Literature DB >> 19040560

Tuberculosis in southern Chinese renal-transplant recipients.

Si-Yang Chen1, Chang-Xi Wang, Li-Zhong Chen, Ji-Guang Fei, Su-Xiong Deng, Jiang Qiu, Jun Li, Gu-Odong Chen, Hong-Mei Fu, Can-Mao Xie.   

Abstract

OBJECTIVES: To analyze the characteristics of tuberculosis (TB) in Southern Chinese renal transplant recipients, and summarize the corresponding experiences in diagnosis and management.
METHOD: Retrospectively study 41 documented post-transplant TB cases out of the 2333 patients who received kidney transplantation in the First Affiliated Hospital of Sun Yat-sen University between Jan. 1991 and Apr. 2007.
RESULTS: TB in the post-renal-transplant population in Southern China displayed the following characteristics: (i) high incidence within a short time after transplantation, the median interval between renal transplantation and diagnosis of TB was 8 months (range: 1-156 months) and 56.1% were diagnosed within the first year post-transplant; (ii) high prevalence (51.2%) of extra-pulmonary tuberculosis; (iii) high co-infection rate (19.5%), pathogens included candida albicans, pseudomonas aeruginosa, staphylococcus aureus, Acinetobacter haemolyticus and cytomegalovirus; (iv) fever (82.9%), cough (56.1%) and sputum (39.0%) are the most common clinical manifestations; (v) purified protein derivative of tuberculin (PPD) skin test had little diagnostic value in this group with a negative result in all 41 cases; (vi) acute rejection (29.3%) and liver function damage (17.1%) were the main adverse effects of anti-tuberculosis chemotherapy; (vii) mortality of patients with post-transplant tuberculosis reached up to 22.0%.
CONCLUSIONS: Chinese renal transplant recipients face a high risk of TB because of their immuno-compromised state and epidemiological prevalence of the disease. Therefore, attention should be given to this differential diagnosis in clinical practice. Balancing the benefits and disadvantages of anti-tuberculosis chemotherapy is of importance for this specific population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040560     DOI: 10.1111/j.1399-0012.2008.00878.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

1.  A tuberculous abscess of the chest wall in a renal allograft recipient.

Authors:  Ye Zhang; Hui Li; Tong Li; Wen-Qian Zhang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 2.  Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.

Authors:  Adam Baghban; Marwan Mikheal Azar; Raffaele Mario Bernardo; Maricar Malinis
Journal:  BMJ Case Rep       Date:  2016-11-16

3.  High-resolution CT findings of pulmonary Mycobacterium tuberculosis infection in renal transplant recipients.

Authors:  Marisa Pereira; Fernando F Gazzoni; Edson Marchiori; Klaus Irion; Jose Moreira; Irai L Giacomelli; Alessandro Pasqualotto; Bruno Hochhegger
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

4.  Gastrointestinal tuberculosis following renal transplantation accompanied with septic shock and acute respiratory distress syndrome: a survival case presentation.

Authors:  Andrea Cikova; Diana Vavrincova-Yaghi; Peter Vavrinec; Anna Dobisova; Andrea Gebhardtova; Zora Flassikova; Mark A Seelen; Robert H Henning; Aktham Yaghi
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

5.  Mycobacterium tuberculosis infection following kidney transplantation.

Authors:  Karima Boubaker; Tahar Gargah; Ezzedine Abderrahim; Taieb Ben Abdallah; Adel Kheder
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.